| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/FBP.0B013E32833DA5DA |
| P8608 | Fatcat ID | release_7ipdnenfyvbpvbri7oxxnjnjoy |
| P698 | PubMed publication ID | 20700048 |
| P50 | author | Livia Pasquali | Q56885067 |
| Carla L Busceti | Q56904752 | ||
| Francesco Fornai | Q56904796 | ||
| P2093 | author name string | Antonio Paparelli | |
| Federica Fulceri | |||
| P2860 | cites work | Regulation of the protein kinase activity of Shaggy(Zeste-white3) by components of the wingless pathway in Drosophila cells and embryos | Q40939820 |
| P433 | issue | 5-6 | |
| P921 | main subject | lithium | Q568 |
| P304 | page(s) | 473-492 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Behavioural Pharmacology | Q15754239 |
| P1476 | title | Intracellular pathways underlying the effects of lithium | |
| P478 | volume | 21 |
| Q47852679 | A Novel Neuroprotective Mechanism for Lithium That Prevents Association of the p75NTR-Sortilin Receptor Complex and Attenuates proNGF-Induced Neuronal Death In Vitro and In Vivo |
| Q42323686 | A fully integrated new paradigm for lithium's mode of action - lithium utilizes latent cellular fail-safe mechanisms |
| Q38760471 | Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro |
| Q38029001 | Autophagy and Its Comprehensive Impact on ALS. |
| Q35967645 | Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor |
| Q24620532 | Clarifying lysosomal storage diseases |
| Q36254308 | Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis |
| Q42486887 | Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway |
| Q64963565 | Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review. |
| Q36059026 | Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome |
| Q37103762 | Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation |
| Q34241205 | Influence of lithium cations on prolyl peptide bonds |
| Q92478501 | Is There a Role of Autophagy in Depression and Antidepressant Action? |
| Q30429650 | Lithium alters the morphology of neurites regenerating from cultured adult spiral ganglion neurons |
| Q36769080 | Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders |
| Q54263446 | Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent. |
| Q37962234 | Lithium in the treatment of neutropenia |
| Q34876367 | Lithium induces ER stress and N-glycan modification in galactose-grown Jurkat cells |
| Q28478124 | Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients |
| Q38333893 | Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease |
| Q35657214 | Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells |
| Q35348419 | Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells |
| Q22241779 | Lithium: the pharmacodynamic actions of the amazing ion |
| Q36894284 | Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres |
| Q28074692 | Mood disorders in the elderly: prevalence, functional impact, and management challenges |
| Q33777958 | Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders |
| Q38608683 | Personalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors. |
| Q30422188 | Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations |
| Q91656798 | Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism |
| Q42143912 | Plastic changes in the spinal cord in motor neuron disease |
| Q64250319 | Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments |
| Q45411894 | Recent advances in the understanding and management of bipolar disorder in adults. |
| Q48024646 | Role of autophagy inhibitors and inducers in modulating the toxicity of trimethyltin in neuronal cell cultures. |
| Q37832687 | Serotonergic agents in the management of cluster headache |
| Q39025471 | Sorafenib and lithium chloride combination treatment shows promising synergistic effects in human glioblastoma multiforme cells in vitro but midkine is not implicated |
| Q27695661 | Structural elucidation of the binding site and mode of inhibition of Li(+) and Mg(2+) in inositol monophosphatase |
| Q35965875 | Telomerase dysregulation in the hippocampus of a rat model of depression: normalization by lithium |
| Q30486745 | The Concise Guide to PHARMACOLOGY 2013/14: enzymes. |
| Q37364244 | Tilapia (Oreochromis mossambicus) brain cells respond to hyperosmotic challenge by inducing myo-inositol biosynthesis |
| Q38803583 | Update on bipolar disorder biomarker candidates. |
| Q47231432 | mTOR-Dependent Cell Proliferation in the Brain. |
Search more.